Us2.ai
PrivateLast Round
Series A
Apr 14, 2022
Total Funding Raised
$19.18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Us2.ai operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in April 2022.
Us2.ai is a healthtech company that provides an AI-powered platform to automate the analysis and reporting of echocardiograms for cardiovascular research and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Us2.ai Comparables
Compare Us2.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ultromics | 91% | |
| Ligence | 88% | |
| iCardio.ai | 84% |
For institutional investors. Book with your work email.
Us2.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 14, 2022 | ||||
| Seed | Jan 7, 2020 | ||||
| Grant | Nov 13, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Us2.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Partech | Series A, Seed |
| Startup SG | Grant |
| A. M. Pappas & Associates | Series A |
| Peak XV Partners | Series A, Seed |
| EDBI | Series A, Seed |
| HEAL Partners | Series A |
| StartUp Health | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 31% MoM.
- Sep 12, 2025
Presented study on cardiac amyloidosis diagnosis at ESC Congress 2025.
For institutional investors. Book with your work email.
Us2.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Us2.ai's valuation, stock price, and market status.
Is Us2.ai a public or private company?
Us2.ai is a private company.
What is the current stock price of Us2.ai?
Us2.ai is a private company, so its shares have no public market price. Caplight tracks Us2.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Us2.ai worth (valuation)?
Valuation information for Us2.ai is not publicly available.
Can I buy Us2.ai stock?
Us2.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Us2.ai's last funding round?
Us2.ai's most recent funding round was Series A on April 14, 2022.
Who are the main investors in Us2.ai?
Key investors in Us2.ai include Peak XV Partners, EDBI, HEAL Partners.
Will Us2.ai IPO soon?
No public IPO plans have been announced for Us2.ai.
How can I track Us2.ai secondary market activity?
Caplight tracks bids, offers, and trades in Us2.ai's shares on secondary markets.